Projects per year
Personal profile
Education
- 2009-2013 Ph.D., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2006-2008 M.S., Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University
- 1993-2000 M.D., School of Medicine, National Taiwan University
Experience
- 2021.08- Director, Department of Surgery, Taipei Medical University Hospital
- Director, Department of Surgery, Taipei Medical University Shuang Ho Hospital
- 2020.08- Director, Division of General Surgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2018.02- Associate Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2013.10-2018.01 Assistant Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2009.02-2013.09 Instructor, Department of Surgery, School of Medicine, Taipei Medical University
- 2005.07-2008.10 Attending Physician, Division of General Surgery, Taipei Tzu Chi Hospital
- 2000.07-2005.06 Resident Physician, Department of Surgery, National Taiwan University Hospital
Research Interests
- Breast cancer, cancer metastasis
Fingerprint
Dive into the research topics where Chin-Sheng Hung is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The Role and Mechanism of Homer Scaffolding Protein3 (Homer3) in Cancer Progression and Therapeutic Response of Breast Cancer
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討Homer Scaffolding Protein3 (Homer3)蛋白在乳癌病程進展，治療反應的角色和機制
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
Dissected the Role of Thrombomodulin in the Clinical Diagnostic and Therapeutic Impacts for Breast Cancer and the Regulation Mechanisms(3/3)
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology
-
Dissected the Role of Thrombomodulin in the Clinical Diagnostic and Therapeutic Impacts for Breast Cancer and the Regulation Mechanisms
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
-
Dissected the Role of Thrombomodulin in the Clinical Diagnostic and Therapeutic Impacts for Breast Cancer and the Regulation Mechanisms
8/1/16 → 7/31/17
Project: A - Government Institution › b - Ministry of Science and Technology
Research output
- 59 Article
-
Neoadjuvant pegylated liposomal doxorubicin- and epirubicin-based combination therapy regimens for early breast cancer: a multicenter retrospective case–control study
Tsai, J. H., Li, C. L., Yeh, D. C., Hung, C. S., Hung, C. C., Lin, C. Y. & Kuo, Y. L., 2023, (Accepted/In press) In: Breast Cancer Research and Treatment. 199, 1, p. 47-55 9 p.Research output: Contribution to journal › Article › peer-review
-
Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53
Wang, W. L., Batzorig, U., Hung, C. S., Wei, P. L., Huang, C. Y. & Chang, Y. J., 2022, In: BioMed Research International. 2022, 1322788.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Human α-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling pathway
Wei, P. L., Lin, J. C., Hung, C. S., Makondi, P. T., Batzorig, U., Chang, T. C., Huang, C. Y. & Chang, Y. J., 2022, In: International Journal of Medical Sciences. 19, 1, p. 34-46 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer
Lin, R. K., Su, C. M., Lin, S. Y., Thi Anh Thu, L., Liew, P. L., Chen, J. Y., Tzeng, H. E., Liu, Y. R., Chang, T. H., Lee, C. Y. & Hung, C. S., Dec 2022, In: Molecular Medicine. 28, 1, 67.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer
Ansar, M., Thu, L. T. A., Hung, C. S., Su, C. M., Huang, M. H., Liao, L. M., Chung, Y. M. & Lin, R. K., Nov 7 2022, In: Frontiers in Oncology. 12, 1004261.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction
Lin, S. (Creator), Ansar, M. (Creator), Hung, C. (Contributor), Lin, R. (Creator), Chang, S. (Contributor), Chen, J. (Creator), Jain, S. (Creator), Liew, P. (Contributor) & Wang, S. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.4974518.v1, https://doi.org/10.6084%2Fm9.figshare.c.4974518.v1
Dataset
-
Additional file 1 of Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction
Wang, S. (Contributor), Chen, J. (Creator), Ansar, M. (Creator), Liew, P. (Contributor), Hung, C. (Contributor), Jain, S. (Creator), Chang, S. (Contributor), Lin, R. (Creator) & Lin, S. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12291872.v1, https://doi.org/10.6084%2Fm9.figshare.12291872.v1
Dataset